GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic AS (OTCPK:BVNKF) » Definitions » Debt-to-Revenue

BVNKF (Bavarian Nordic AS) Debt-to-Revenue : 0.02 (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Bavarian Nordic AS Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Bavarian Nordic AS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $5.6 Mil. Bavarian Nordic AS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $11.4 Mil. Bavarian Nordic AS's annualized Revenue for the quarter that ended in Sep. 2024 was $811.8 Mil. Bavarian Nordic AS's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 was 0.02.


Bavarian Nordic AS Debt-to-Revenue Historical Data

The historical data trend for Bavarian Nordic AS's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic AS Debt-to-Revenue Chart

Bavarian Nordic AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.77 0.25 0.60 0.56 0.02

Bavarian Nordic AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.04 0.02 0.02

Competitive Comparison of Bavarian Nordic AS's Debt-to-Revenue

For the Biotechnology subindustry, Bavarian Nordic AS's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bavarian Nordic AS's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bavarian Nordic AS's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic AS's Debt-to-Revenue falls into.



Bavarian Nordic AS Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Bavarian Nordic AS's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(6.81 + 14.449) / 1033.291
=0.02

Bavarian Nordic AS's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(5.605 + 11.409) / 811.768
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2024) Revenue data.


Bavarian Nordic AS Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic AS's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Bavarian Nordic AS Business Description

Address
Philip Heymans Alle 3, Hellerup, DNK, DK-2900
Bavarian Nordic A/S is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.

Bavarian Nordic AS Headlines

From GuruFocus

Q3 2023 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q3 2021 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2023 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2021 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q3 2022 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2022 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2019 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2022 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024